MICAH BUCKEL: Open Payments
NPI 1902200413 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,426 in 76 payments from 23 companies in 2025. Trend: 2023 $1,461 · 2024 $1,860 · 2025 $1,426
Food & beverage: $1,413Education: $12
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 18 | $245 |
| Lilly USA, LLC | 13 | $215 |
| AstraZeneca Pharmaceuticals LP | 4 | $197 |
| Novo Nordisk Inc | 10 | $164 |
| Gilead Sciences, Inc. | 4 | $72 |
| ABBVIE INC. | 4 | $69 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Alnylam Pharmaceuticals Inc. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
| SANOFI-AVENTIS U.S. LLC | 2 | $37 |
Products named: FARXIGA, NURTEC ODT, MOUNJARO, Ozempic, ELIQUIS, Wegovy, Auvelity, JARDIANCE.
Industry payments across KY — which companies pay providers there.
